On a Saturday evening in late September, about three weeks before the Journal published my first story, an email arrived in the in-box of Gary Yamamoto, the veteran CMS field inspector who had dropped in unannounced at the old Facebook building in 2012 and lectured Sunny Balwani about lab regulations. Under the subject line "CMS Complaint: Theranos Inc.," it began:

Dear Gary,

…

…

…

 

>> 网页版功能未完善，完整内容，请使用微信小程序。